Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective study.
Rashid N, Slade M, Abboud R, Gao F, DiPersio JF, Westervelt P, Uy G, Stockerl-Goldstein K, Romee R, Schroeder MA. Rashid N, et al. Among authors: slade m. Transpl Int. 2020 Sep;33(9):1089-1098. doi: 10.1111/tri.13659. Epub 2020 Jun 19. Transpl Int. 2020. PMID: 32468720 Free PMC article.
Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma.
Slade M, Martin TG, Nathwani N, Fiala MA, Rettig MP, Gao F, Deol A, Buadi FK, Kaufman JL, Hofmeister CC, Gregory TK, Berdeja J, Chari A, Rosko A, Vij R. Slade M, et al. Leukemia. 2022 Dec;36(12):2917-2921. doi: 10.1038/s41375-022-01691-1. Epub 2022 Sep 16. Leukemia. 2022. PMID: 36114265 Free PMC article. Clinical Trial. No abstract available.
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone.
Loncharich AJ, Fiala MA, Slade MJ, Vickroy A, Kavanaugh M, Wilson C, Schroeder MA, Stockerl-Goldstein K, Vij R, Sanfilippo KM. Loncharich AJ, et al. Among authors: slade mj. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):825-828. doi: 10.1016/j.clml.2023.07.009. Epub 2023 Jul 23. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37543510
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial.
Slade M, Fiala MA, Kirchmeyer M, King J, Gao F, Schroeder MA, Stewart AK, Stockerl-Goldstein K, Chen C, Vij R. Slade M, et al. Transplant Cell Ther. 2023 Dec;29(12):764.e1-764.e7. doi: 10.1016/j.jtct.2023.09.014. Epub 2023 Sep 22. Transplant Cell Ther. 2023. PMID: 37741459 Free article. Clinical Trial.
625 results